A clinical comparative study of preoperative clinical staging and surgical and histopathological staging in endometrial carcinoma

Authors

  • Priya Bulchandani Department of Obstetrics and Gynecology, Grant Government Medical College, JJ Group of Hospitals, Mumbai, Maharashtra, India
  • Tushar Palve Department of Obstetrics and Gynecology, Grant Government Medical College, JJ Group of Hospitals, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20230547

Keywords:

Clinical staging, Surgical staging, Histopathological staging, Endometrial carcinoma

Abstract

Background: Endometrial cancer is the fourth most common carcinoma in women across the globe. Treatment and prognosis are influenced by surgical international federation of gynecology and obstetrics staging system with evaluation of the depth of myometrium invasion, cervical extension and the presence of lymph node and distant metastasis. This study aims to compare the MRI findings in preoperative staging of endometrial carcinoma with intra-operative findings and revised international federation of gynecology and obstetrics staging based on postoperative histopathology.

Methods: The study was prospectively carried out in department of obstetrics and gynecology of a Cama Hospital, Mumbai for a total period of 1.5 years; 30 patients diagnosed with endometrial carcinoma were selected.

Results: The patients were predominantly multiparous with most common presenting complaint as postmenopausal bleeding. The clinical- radiological staging was concordant with histopathological staging in 60% (18/30) cases. Upstaging was seen in 10% (3/30 cases), while 30% (9/30) showed down staging in the final histopathology. While comparing the surgical intra-operative staging, it was seen to corroborate with the final histopathology in 63.33% (19/30) cases.

Conclusions: The pre-operative radiological assessment especially MRI with high accuracy in determining myometrial invasion is an inseparable tool. The surgeon would have to rely on intra-operative assessment for further plan of action and effectively dealing with carcinoma.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.

Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018; 29(1):e7.

Shrivastava S, Barmon D, Kataki A, Deka P, Sharma J, Choudhary B, et al. Magnetic resonance imaging in pre-operative staging of endometrial cancer. Indian J Cancer. 2016;53(1):181-5.

Clarke BA, Gilks CB. Endometrial carcinoma: Controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol. 2010;63(5):410-5.

Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103-4.

Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, Leitao MM, Chi DS, et al. The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2011;21(3):511-6.

Haltia UM, Bützow R, Leminen A, Loukovaara M. FIGO 1988 versus 2009 staging for endometrial carcinoma: A comparative study on prediction of survival and stage distribution according to histologic subtype. J Gynecol Oncol. 2014;25(1):30-5.

Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynecol Obstet. 2018; 143(2):37-50.

Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23(16):3668-75.

Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer. 1997;75(12):1836-41.

Khoury‐Collado F, St. Clair C, Abu‐Rustum NR. Sentinel lymph node mapping in endometrial Cancer: An Update. Oncologist. 2016;21(4):461-6.

Zandrino F, La Paglia E, Musante F. Magnetic resonance imaging in local staging of endometrial carcinoma: Diagnostic performance, pitfalls, and literature review. Tumori. 2010;96(4):601-8.

Mubarak F, Akhtar MW, Gul-e-Khanda, Husen YA. Staging of endometrial carcinoma by Magnetic Resonance Imaging: Correlation with surgery and histopathology. J Pak Med Assoc. 2009;59(9):622-5.

Andreano A, Rechichi G, Rebora P, Sironi S, Valsecchi MG, Galimberti S. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: A systematic review and meta-analysis. Eur Radiol. 2014;24(6):1327-38.

Goudge C, Bernhard S, Cloven NG, Morris P. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol. 2004;93(2):536-9.

Kirby TO, Leath CA, Kilgore LC. Surgical staging in endometrial cancer. Oncology (Williston Park). 2006; 20(1):45-50.

Rungruang B, Olawaiye AB. Comprehensive surgical staging for endometrial cancer. Rev Obstet Gynecol. 2012;5(1):28-34.

Orr JW, Holloway RW, Orr PF, Holimon JL. Surgical staging of uterine cancer: an analysis of perioperative morbidity. GynecolOncol. 1991;42(3):209-16.

Jones R, Chen Q, Best R, Libby B, Crandley EF, Showalter TN. Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer. Radiat Oncol. 2014;24;9:164.

Momeni M, Kolev V, Cardenas-Goicoechea J, Getrajdman J, Fishman D, Chuang L, et al. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens? Am J Obstet Gynecol. 2013;208(1):71e1-6.

Felix AS, Yang HP, Bell DW, Sherman ME. Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. AdvExp Med Biol. 2017;943:3-46.

Dalal VK, Dave PS, Patel B, Patel SM, Parekh C. Carcinoma Endometrium in Women aged 30 Years and Younger: An Unusual Age of Presentation. Indian J Gynecol Oncol 2020;8:57.

Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59(4):1055-60.

Wu QJ, Li YY, Tu C, Zhu J, Qian KQ, Feng TB, et al. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep. 2015;5:14243.

Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, et al. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control. 2015; 26(2):287-96.

Zhou Q, Singh R, Yunzhe L, Mo Z, Huang J. Preoperative histopathological grading and clinical staging versus surgico-pathological grading and surgical staging in endometrial carcinoma patients: a single centre retrospective study. Glob J Med Res E Gynecol Obstet. 2018;18(1):19-28.

Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, et al. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer. 2019;145(7):1719-30.

Bi Q, Chen Y, Wu K, Wang J, Zhao Y, Wang B, et al. The Diagnostic Value of MRI for Preoperative Staging in Patients with Endometrial Cancer: A Meta-Analysis. Acad Radiol. 2020;27(7):960-8.

Rechichi G, Galimberti S, Signorelli M, Franzesi CT, Perego P, Valsecchi MG, et al. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol. 2011; 197(1):256-62.

Ali AT. Risk factors for endometrial cancer. CeskaGynekol. 2013;78(5):448-59.

Tamai K, Koyama T, Saga T, Umeoka S, Mikami Y, Fujii S, et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imag. 2007; 26(3):682-7.

Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer. 2007;17(1):188-96.

Cowles TA, Magrina JF, Masterson BJ, Capen CV. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol. 1985; 66(3):413-6.

Lewis BV, Stallworthy JA, Cowdell R. Adenocarcinoma of the body of the uterus. J Obstet Gynaecol Br. 1970;77(4):343-8.

Vorgias G, Lekka J, Katsoulis M, Varhalama E, Kalinoglou N, Akrivos T. Diagnostic accuracy of prehysterectomy curettage in determining tumor type and grade in patients with endometrial cancer. Med Gen Med. 2003;5(4):7.

Su H, Huang L, Huang KG, Yen CF, Han CM, Lee CL. Accuracy of hysteroscopic biopsy, compared to dilation and curettage, as a predictor of final pathology in patients with endometrial cancer. Taiwan J Obstet Gynecol. 2015;54(6):757-60.

Visser NCM, Reijnen C, Massuger LFAG, Nagtegaal ID, Bulten J, Pijnenborg JMA. Accuracy of endometrial sampling in endometrial carcinoma: a systematic review and meta-analysis. Obstet Gynecol. 2017;130(4):803-13.

Barut A, Barut F, Arikan I, Harma M, Harma MI, Ozmen Bayar UO. Comparison of the histopathological diagnoses of preoperative dilatation and curettage and hysterectomy specimens. J Obstet Gynaecol Res. 2012; 38(1):16-22.

Downloads

Published

2023-02-27

Issue

Section

Original Research Articles